Biogen Idec’s Mullen defends business moves

SAN FRANCISCO - Chief executive James C. Mullen strongly defended Biogen Idec Inc.’s business moves yesterday at a biotechnology investors conference - eight days after the Cambridge company said Mullen will soon retire. (Full article: 419 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly